Cognitive Rehabilitation for Post-COVID-19 Cognitive Impairment
Study Phase: N/A
Recruitment Status: Recruiting
Start Date: September 01, 2022
End Date: June 01, 2023
Megan McVeety
Inclusion Criteria:
- Adults ≥18 years of age
- Have a confirmed SARS-CoV-2 infection (positive PCR or are serum antibody positive [against spike protein if unvaccinated or N-capsid peptide if vaccinated])
- Speak English
- Have objective mild to moderate cognitive impairment, which will be defined as impairment in executive function (a z-score >1.5 standard deviations below the normative mean) and in at least one other cognitive domain
- Endorse comfort and familiarity with technology.
Exclusion Criteria:
- No method of contact
- Major neurocognitive disorder, as defined by a score <17 on the Montreal Cognitive Assessment (MoCA)
- History of pre-COVID-19 neurologic disease (e.g., stroke)
- History of severe head injury (as defined by loss of consciousness >30 minutes)
- Ongoing substance use disorder (Mini International Neuropsychiatric Interview Version 7.0.2 [MINI] or Alcohol Use Disorders Test-Consumption [AUDIT-C] >8)
- Unstable medical, neurologic, or psychiatric conditions precluding participation in research activities, and
- Contraindication for MRI (e.g., metallic/electronic implants).
- Not involved in cognitive rehabiliation/training or daily meditative practices during study enrollment
-
Conditions:
- Cognitive Dysfunction